CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MyBiotics is developing novel probiotic solutions targeting specific health issues such as obesity and depression. Utilizing a unique delivery technology, these probiotics aim to effectively colonize the gastrointestinal tract and provide therapeutic benefits.
Development of novel probiotic solutions for specific illnesses and health problems, ex:
Obesity, Depression, Crohn or Colitis diseases.The solutions proposed by MyBiotics will use Mycrobe TM a delivery technology to overpass the biologic barriers :gastric acid, pancreatic juice and bile salts, and deliver sufficient quantity of living probiotic directly to colonize the gastro intestinal tract were they are therapeutically efficient.MyBiotics will design for each targeted disease a set of specif…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
